Trauma can deeply disrupt psychological, emotional, and neurobiological systems. Because its impact is so pervasive, clients presenting with a history of trauma or PTSD frequently meet the criteria for other mental health conditions as well.
This guide is designed to help Rula providers recognize common co-occurring presentations, differentiate overlapping symptoms, and make informed clinical decisions when tailoring treatment plans for complex trauma presentations.
Co-Occurring Presentations in Trauma-Informed Care
When working with trauma, navigating co-occurring presentations is commonplace. Clients who have experienced chronic or acute trauma frequently experience secondary conditions, most notably:
- Depressive disorders
- Anxiety disorders
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Substance use disorders
Failing to recognize co-occurring conditions might lead to stalled treatment progress, while misattributing trauma symptoms to separate disorders can lead to overdiagnosis and labeling. A structured diagnostic process requires looking at the client’s symptom presentation through a trauma-informed lens.
Differentiating Overlapping Symptoms
Many diagnostic criteria for anxiety, depression, and ADHD overlap significantly with the core clusters of PTSD (Intrusion, Avoidance, Cognition/Mood, and Arousal/Reactivity). Use the clinical distinctions below to help guide your differential assessment:
Trauma and Depression
- Overlap: Both presentations feature anhedonia, social withdrawal, negative self-beliefs, sleep disturbances, and psychomotor agitation or retardation.
- Distinction: In pure Major Depressive Disorder (MDD), the negative mood and low energy are often generalized and pervasive. In PTSD, emotional numbing and withdrawal are often tied to the avoidance of trauma reminders, or fueled by trauma-specific cognitions of shame, guilt, or a lack of safety.
Trauma and Anxiety
- Overlap: Both present with autonomic hyperactivity, restlessness, irritability, muscle tension, sleep difficulties, and hypervigilance.
- Distinction: Generalized Anxiety Disorder (GAD) is typically characterized by uncontrollable, future-oriented worry across multiple domains (finances, health, relationships). PTSD-related anxiety is generally rooted in past-oriented threat assessment, physiological hyperarousal, and safety-seeking behaviors designed to prevent a recurrence of the trauma.
Trauma and ADHD
- Overlap: Both involve significant executive dysfunction, emotional dysregulation, restlessness, forgetfulness, and difficulties with sustained attention or concentration.
- Distinction: In ADHD, executive functioning deficits are neurodevelopmental and typically present consistently across the lifespan, and must have begun before age 12, regardless of environmental threat. In trauma presentations, concentration problems are often secondary to a brain stuck in a survival state (e.g., hypervigilance tracking external threats, or internal dissociation and flashbacks taking up cognitive bandwidth).
| When diagnosing ADHD in a client with a significant trauma history, assess whether the executive dysfunction worsens during periods of trauma activation or if it remains static across all life stages and environments. |
Clinical Decision-Making: Integrated vs. Sequential Treatment
When a client presents with multiple severe conditions alongside trauma, determining where to begin can be challenging. Clinical best practices suggest two primary approaches:
Integrated Treatment (Recommended)
Whenever possible, treat trauma and co-occurring symptoms concurrently. Evidence-based trauma treatments (such as CPT, Prolonged Exposure (PE), and EMDR) are highly effective at reducing secondary depressive and anxious symptoms. By treating the root trauma, you often alleviate the driving force behind the client's co-occurring mood disturbances.
Sequential Treatment (When Stabilization is Needed)
There are clinical scenarios where a co-occurring presentation needs to be stabilized before beginning intensive, trauma-focused exposure work. Consider a sequential approach if the co-occurring condition directly impedes safety or treatment engagement:
- Acute Risk: Severe, active suicidality or self-harm (requires immediate safety planning or emergency response).
- Severe Substance Use: Active, unmanaged substance use (including dependence) that impairs the client’s cognitive capacity to reprocess memories or safely tolerate emotional distress.
- Severe Depressive Symptoms: If a client lacks the baseline energy or motivation to attend sessions or complete therapeutic tasks, initial behavioral activation (MDD focus) may be required to build the foundational stamina needed for trauma processing.
Utilizing Measurement-Informed Care (MIC) for Complex Presentations
Tracking multiple symptom domains simultaneously helps clarify the relationship between trauma and co-occurring conditions. Rula’s Library of On-Demand Measures allows you to bundle tools to monitor progress holistically:
- PCL-5 + PHQ-9: Watch for whether drops in PTSD symptoms precede or parallel improvements in depressive severity.
- PCL-5 + GAD-7: Helps track whether somatic anxiety decreases as trauma triggers are successfully desensitized or reprocessed.
By reviewing these measures routinely with your client, you can practice shared decision-making regarding the pacing, intensity, and direction of therapy. Please note, the PCL-5 is administered on a monthly cadence, whereas PHQ-9 and GAD-7 follow a biweekly administration schedule.
Rula Resources to Support Complex Care
To assist you in managing complex cases with co-occurring presentations, utilize the following pathways within the Rula ecosystem:
- Psychiatric Medication Management: If a client's co-occurring depression, anxiety, or ADHD is severely limiting their ability to engage in trauma work, a combination of psychotherapy and medication management is often the gold standard.
- Higher Level of Care (HLOC): If a client’s co-occurring presentations create acute safety risks or render outpatient care insufficient, Rula’s care coordination team can assist in transitioning them to intensive outpatient (IOP) or partial hospitalization programs (PHP).
To submit a referral, complete the Provider Referral Form.
References
Adams, Z., Adams, T., Stauffacher, K., Mandel, H., & Wang, Z. (2015). The effects of inattentiveness and hyperactivity on posttraumatic stress symptoms: Does a diagnosis of posttraumatic stress disorder matter? Journal of Attention Disorders, 24(11), 1246–1254. https://doi.org/10.1177/1087054715580846
Back, S. E., Jarnecke, A. M., Norman, S. B., Zaur, A. J., & Hien, A. A. (2024). State of the science: Treatment of comorbid posttraumatic stress disorder and substance use disorders. Journal of Traumatic Stress, 37(5), 803–813. https://doi.org/10.1002/jts.23049
Gielen, N., Krumeich, A., Havermans, R. C., Smeets, F., & Jansen, A. (2014). Why clinicians do not implement integrated treatment for comorbid substance use disorder and posttraumatic stress disorder: a qualitative study. European Journal of Psychotraumatology, 5(1). https://doi.org/10.3402/ejpt.v5.22821
Magdi, H. M., Abousoliman, A. D., Ibrahim, A. M., Elsehrawy, M. G., EL-Gazar, H. E., & Zoromba, M. A. (2025). Attention-deficit/hyperactivity disorder and post-traumatic stress disorder adult comorbidity: a systematic review. Systematic Reviews, 14(1). https://doi.org/10.1186/s13643-025-02774-7
Updated